Related Experiment Video
Updated: Apr 7, 2026
Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
Published on: September 20, 2019
MYC Is a Major Determinant of Mitotic Cell Fate
Caroline Topham1, Anthony Tighe1, Peter Ly2
1Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Abstract:
Taxol and other antimitotic agents are frontline chemotherapy agents but the mechanisms responsible for patient benefit remain unclear. Following a genome-wide siRNA screen, we identified the oncogenic transcription factor Myc as a taxol sensitizer. Using time-lapse imaging to correlate mitotic behavior with cell fate, we show that Myc sensitizes cells to mitotic blockers and agents that accelerate mitotic progression. Myc achieves this by upregulating a cluster of redundant pro-apoptotic BH3-only proteins and suppressing pro-survival Bcl-xL. Gene expression analysis of breast cancers indicates that taxane responses correlate positively with Myc and negatively with Bcl-xL. Accordingly, pharmacological inhibition of Bcl-xL restores apoptosis in Myc-deficient cells. These results open up opportunities for biomarkers and combination therapies that could enhance traditional and second-generation antimitotic agents.
Insights
The oncogenic transcription factor Myc sensitizes cancer cells to chemotherapy agents like Taxol. Myc enhances cell death by altering apoptosis-related protein levels, suggesting new combination therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Antimitotic agents, including Taxol, are crucial chemotherapy drugs.
- The precise mechanisms underlying patient response to these agents are not fully understood.
Purpose of the Study:
- To identify factors that sensitize cancer cells to antimitotic agents.
- To elucidate the role of the oncogenic transcription factor Myc in Taxol response.
Main Methods:
- Genome-wide siRNA screening to identify sensitizing factors.
- Time-lapse imaging to correlate cell division dynamics with cell death.
- Gene expression analysis in breast cancer samples.
- Pharmacological inhibition of Bcl-xL.
Main Results:
- The oncogenic transcription factor Myc was identified as a Taxol sensitizer.
- Myc enhances sensitivity to mitotic blockers and agents accelerating mitotic progression.
- Myc upregulates pro-apoptotic BH3-only proteins and suppresses pro-survival Bcl-xL.
- Taxane response in breast cancers correlates with Myc levels and inversely with Bcl-xL.
- Inhibiting Bcl-xL restored apoptosis in Myc-deficient cells.
Conclusions:
- Myc plays a significant role in sensitizing cells to antimitotic chemotherapy.
- The Myc-mediated regulation of apoptosis proteins (BH3-only and Bcl-xL) is key to this sensitization.
- Findings suggest potential for Myc and Bcl-xL as biomarkers for taxane response.
- These discoveries open avenues for novel combination therapies to improve antimitotic agent efficacy.
More Related Videos
Related Concept Videos
02:38Mitogens and the Cell Cycle
02:38Mitogens and the Cell Cycle
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:15M-Cdk Drives Transition Into Mitosis
01:27Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
02:23Abnormal Proliferation